$4.55 0.04 (+0.89%)
12/3/2009 3:59 PM

Nymox Pharmaceutical Corp (NYMX)

CAPS Rating: 1 out of 5

A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

Current Price $4.55 Mkt Cap $141.58M
Open $4.62 P/E Ratio 0.00
Prev. Close $4.51 Div. (Yield) N/A (N/A)
Daily Range $4.42 - $4.62 Volume 10,050
52-Wk Range $2.20 - $7.07 Avg. Daily Vol. 22,000

NYMX News and Commentary

Related News and Articles

Caps

How do you think NYMX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

38 Outperform
26 Underperform
 

All-Star Members

8 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYMX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Voyt608 (69.91)
Submitted April 12, 2007

Non estrogenic treatment for benign proatatic hyperplasia with proven efficacy ih reducing symptoms such as frepuent voiding, urgency, nocturia, dripping etc. No significant side effects and a 30% reduction in prostate size in late trials. Tremendous… More

NeroSagetrade (90.80)
Submitted October 11, 2007

There are far too many of these types of pharmaceutical companies out there...plenty of promise, huge valuation and failure to deliver. Nymox currently has one...yes..only one drug currently in late stage trials to treat enlarging prostates. The… More

NYMX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about NYMX.

Recs

0
Member Avatar shupenobama (22.02) Submitted: 11/27/2009 7:54:04 PM : Outperform Start Price: $4.30 NYMX Score: +4.99

will explode when BPH treatment nears approval

Recs

0
Member Avatar TSIF (98.76) Submitted: 8/27/2009 1:49:19 PM : Outperform Start Price: $6.60 NYMX Score: -38.47

Occasionally, while trying to net some points on CAPs, I let the 20 minute wait rule on CAPs get me rattled. I open and close my down thrumbs several times trying to time a peak. Several times now, in my haste, I've let the stock pick activate after opening and cancelling it a few times, and not changing the pick to down on the last cycle, leaving me in the WRONG direction. Most pharaceuticals, in early trials will get some positive news that drives the speculators, looking for a Dendron or HGSI type gain. Typically the buy on the news is overdone and profit takers get a few cycles. These are often promising companies, but from the CAPs perspective of "short run" they aren't likely to pan out until the FDA gets it's day. I do like Nymox's chances, and I have friends suffering from Liver Cancer. In the long run, I might be a buyer, possibley even at todays $4.75 price. The $7.07 this spiked to, just a few days ago when I attempted to swing trade it on caps and wrong way'd it, was clearly a market "over" reaction. Like my green thumb, those buying at $7.07 will come out ahead, if they hold, and Nymox progresses further into the FDA cycle. If proven safe and effective, then those willing to incur the risk by getting in early stand the most to gain. Best of luck to Nymox long holders. I expect to turn this pick green in the future, but lower starting price would have been nicer! Swing trading is best done by those with more time to "play" and better attention spans, (real time opening and closing bids would help)!

Recs

0
Member Avatar mepedrou (< 20) Submitted: 1/8/2009 2:28:58 PM : Outperform Start Price: $3.55 NYMX Score: +3.66

nx 1207 drug a guaranteed winner

Leaderboard

Find the members with the highest scoring picks in NYMX.

Score Leader

padams123

padams123 (< 20) Score: +42.08

The Score Leader is the member with the highest score across all their picks in NYMX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
padams123 < 20 11/21/2006 Outperform 5Y $3.63 +25.34% -16.74% +42.08
johngarcia13 59.86 12/7/2006 Outperform 1Y $3.69 +23.31% -17.59% +40.90
nexare < 20 10/5/2006 Outperform 3W $3.95 +15.19% -13.15% +28.34
Lisalbo 67.21 10/16/2006 Outperform 5Y $4.05 +12.35% -14.18% +26.52
jeromeluther < 20 2/6/2007 Outperform 5Y $4.70 -3.19% -19.19% +15.99 1 Comment
BetapegAnalytics 86.12 8/18/2009 Underperform 5Y $4.51 +0.89% +12.56% +11.67
raisethesky < 20 9/24/2007 Outperform NS $5.25 -13.33% -24.13% +10.79
dplindeman 99.29 11/6/2009 Underperform NS $4.90 -7.14% +3.54% +10.68
1st2 < 20 1/8/2009 Outperform NS $3.40 +33.82% +24.27% +9.55
Fastball07 35.37 11/20/2007 Underperform 3M $6.40 -28.91% -19.71% +9.20

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NYMX.

Featured Broker Partners